The Journal of Allergy and Clinical Immunology
Volume 111, Issue 1 , Pages 24-32, January 2003

Mast cells: Beyond IgE☆☆

Division of Rheumatology, Immunology, and Allergy, Harvard Medical School, Brigham and Women's Hospital, Boston. Boston, Mass

Received 7 October 2002; accepted 16 October 2002.

Abstract 

Continuing Medical Education examination

CONTINUING MEDICAL EDUCATION ARTICLE Credit can now be obtained, free for a limited time, by reading the following review. Please note the instructions listed below. Method of Physician Participation in Learning Process: The core material for this activity can be read in this issue of the Journal or online at the JACI Web site: www.mosby.com/jaci . The accompanying test may only be submitted online at www.mosby.com/jaci . Fax or other copies will not be accepted. Date of Original Release: January 2003. Credit may be obtained for this course until December 31, 2003. Copyright Statement: Copyright © 2003-2004. All rights reserved. List of Design Committee Members: Authors: Donald Y. M. Leung, MD, PhD, FAAAAI, John W. Bloom, MD Overall Purpose/Goal: To provide excellent reviews on key aspects of allergic disease to those who research, treat, or manage allergic disease. Target Audience: Physicians and researchers within the field of allergic disease. Activity Objectives (a) To understand the molecular mechanisms of glucocorticoid action. (b) To recognize potential mechanisms of glucocorticoid resistance. (c) To review evaluation and management of patients with glucocorticoid resistance. Accreditation/Provider Statements and Credit Designation: The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AAAAI designates this educational activity for up to 1.0 hour in Category I credit towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit he or she actually spent in the educational activity. Recognition of Commercial Support: This activity has been funded through an unrestricted educational grant from GlaxoSmithKline.

Keywords:  Mast cells, IL-4, cysteinyl leukotrienes, cysteinyl leukotriene 1 receptor, uridine diphosphate

Abbreviations:  AA , Arachidonic acid, CysLT , Cysteinyl leukotriene, FLAP , 5-Lipoxygenase activating protein, GPCR , G protein-coupled receptor, 5-LO , 5-Lipoxygenase, LT , Leukotriene, LTC4S , Leukotriene C4 synthase, PG , Prostaglandin, TLR , Toll-like receptor, UDP , Uridine diphosphate

 

 Supported by National Institutes of Health grants AI31599, HL36110, AI48802, and AI52353 and by grants from the Charles Dana Foundation and the Vinik Family Fund for Research in Allergic Diseases in Children.

☆☆ Reprint requests: Joshua A. Boyce, MD, Harvard Medical School, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Smith Research Building, Room 626, 1 Jimmy Fund Way, Boston, MA 02199.

PII: S0091-6749(02)91322-9

doi:10.1067/mai.2003.60

The Journal of Allergy and Clinical Immunology
Volume 111, Issue 1 , Pages 24-32, January 2003